These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 24789782

  • 1. Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.
    Schwaiger J, Aberle JH, Stiasny K, Knapp B, Schreiner W, Fae I, Fischer G, Scheinost O, Chmelik V, Heinz FX.
    J Virol; 2014 Jul; 88(14):7828-42. PubMed ID: 24789782
    [Abstract] [Full Text] [Related]

  • 2. Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.
    Jarmer J, Zlatkovic J, Tsouchnikas G, Vratskikh O, Strauß J, Aberle JH, Chmelik V, Kundi M, Stiasny K, Heinz FX.
    J Virol; 2014 Dec; 88(23):13845-57. PubMed ID: 25253341
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.
    Tsouchnikas G, Zlatkovic J, Jarmer J, Strauß J, Vratskikh O, Kundi M, Stiasny K, Heinz FX.
    J Virol; 2015 Aug; 89(15):7970-8. PubMed ID: 26018152
    [Abstract] [Full Text] [Related]

  • 6. Single-dose vaccine against tick-borne encephalitis.
    Rumyantsev AA, Goncalvez AP, Giel-Moloney M, Catalan J, Liu Y, Gao QS, Almond J, Kleanthous H, Pugachev KV.
    Proc Natl Acad Sci U S A; 2013 Aug 06; 110(32):13103-8. PubMed ID: 23858441
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis.
    Stiasny K, Aberle JH, Keller M, Grubeck-Loebenstein B, Heinz FX.
    PLoS One; 2012 Aug 06; 7(3):e34145. PubMed ID: 22461903
    [Abstract] [Full Text] [Related]

  • 12. Field effectiveness of vaccination against tick-borne encephalitis.
    Heinz FX, Holzmann H, Essl A, Kundi M.
    Vaccine; 2007 Oct 23; 25(43):7559-67. PubMed ID: 17869389
    [Abstract] [Full Text] [Related]

  • 13. Highly specific detection of antibodies to tick-borne encephalitis (TBE) virus in humans using a domain III antigen and a sensitive immune complex (IC) ELISA.
    Ludolfs D, Reinholz M, Schmitz H.
    J Clin Virol; 2009 Jun 23; 45(2):125-8. PubMed ID: 19409841
    [Abstract] [Full Text] [Related]

  • 14. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG, Bray M, Hanley KA, Speicher J, Elkins R.
    J Virol; 2001 Sep 23; 75(17):8259-67. PubMed ID: 11483771
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.